ePortal Documents

Dermatological breakthroughs at MedUni Vienna

4/25: New CD Laboratory helps psoriasis patients

Head of Laboratory Georg Stary and his team are researching the molecular mechanisms underlying diseases such as psoriasis at the new CD Laboratory for Chronic Inflammatory Skin Diseases at the Medical University of Vienna, supported by commercial partner Janssen-Cilag Pharma GmbH, a Johnson & Johnson company. This basic research aims to enable the prediction of the effectiveness of therapies and the development of new treatment approaches to improve the quality of life of affected patients.

From left to right: MedUni Vienna's Vice Rector for Research and Innovation Michaela Fritz, Wolfgang Peter Weninger (Head of Department at the University Clinic for Dermatology, MedUni Vienna), Head of Laboratory Georg Stary, Sylvia Knapp (Member of the CDG Scientific Board and Head of Research Division Infection Biology at the University Clinic for Internal Medicine I, MedUni Vienna) and Sara Leitao (Managing Director Janssen-Cilag Pharma GmbH, a Johnson & Johnson company).

Press release (MedUni Vienna)

Further information on the CD Laboratory

Head of Laboratory Prof. Stary works with cell cultures to analyse and better understand the position of immune cells in the skin.

CD Laboratory for Chronic Inflammatory Skin Diseases

Head of research unit

Univ.Prof. Dr. Georg Stary

Medizinische Universität Wien

Duration

01.10.2024 - 30.09.2031

Commercial Partner

Janssen-Cilag Pharma GmbH, a Johnson & Johnson company

Christian Doppler Forschungsgesellschaft

Boltzmanngasse 20/1/3 | 1090 Wien | Tel: +43 1 5042205 | Fax: +43 1 5042205-20 | office@cdg.ac.at

© 2020 Christian Doppler Forschungsgesellschaft